Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles ; volume:4 ; number:1 ; day:9 ; month:1 ; year:2024 ; pages:33-47 ; date:1.2024
Nature aging ; 4, Heft 1 (9.1.2024), 33-47, 1.2024
- Urheber
-
Tijms, Betty M.
Vromen, Ellen M.
Mjaavatten, Olav
Holstege, Henne
Reus, Lianne M.
Lee, Sven van der
Wesenhagen, Kirsten E. J.
Lorenzini, Luigi
Vermunt, Lisa
Venkatraghavan, Vikram
Tesi, Niccoló
Tomassen, Jori
Braber, Anouk den
Goossens, Julie
Vanmechelen, Eugeen
Barkhof, Frederik
Pijnenburg, Yolande A. L.
Flier, Wiesje M. van der
Teunissen, Charlotte E.
Berven, Frode S.
Visser, Pieter Jelle
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s43587-023-00550-7
- URN
-
urn:nbn:de:101:1-2024040212330854640269
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tijms, Betty M.
- Vromen, Ellen M.
- Mjaavatten, Olav
- Holstege, Henne
- Reus, Lianne M.
- Lee, Sven van der
- Wesenhagen, Kirsten E. J.
- Lorenzini, Luigi
- Vermunt, Lisa
- Venkatraghavan, Vikram
- Tesi, Niccoló
- Tomassen, Jori
- Braber, Anouk den
- Goossens, Julie
- Vanmechelen, Eugeen
- Barkhof, Frederik
- Pijnenburg, Yolande A. L.
- Flier, Wiesje M. van der
- Teunissen, Charlotte E.
- Berven, Frode S.
- Visser, Pieter Jelle
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Molecular subtypes of Alzheimer’s disease
Pathophysiological subtypes of mild cognitive impairment due to Alzheimer’s disease identified by CSF proteomics
Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease
The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
Cerebrospinal Fluid of Patients With Alzheimer’s Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Molecular subtypes of Alzheimer’s disease
Pathophysiological subtypes of mild cognitive impairment due to Alzheimer’s disease identified by CSF proteomics
Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease
The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
Cerebrospinal Fluid of Patients With Alzheimer’s Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Molecular subtypes of Alzheimer’s disease
Pathophysiological subtypes of mild cognitive impairment due to Alzheimer’s disease identified by CSF proteomics
Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease
The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
Cerebrospinal Fluid of Patients With Alzheimer’s Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease